These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 12473590

  • 1. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G.
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [Abstract] [Full Text] [Related]

  • 2. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
    Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K.
    Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
    Ota N, Kawakami K, Okuda T, Takehara A, Hiranuma C, Oyama K, Ota Y, Oda M, Watanabe G.
    Anticancer Res; 2006 Aug; 26(5B):3729-32. PubMed ID: 17094392
    [Abstract] [Full Text] [Related]

  • 5. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC, Lam SY, Tsang KW, Lam B, Ho JC, Fu KH, Lam WK, Kwong YL.
    Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
    [Abstract] [Full Text] [Related]

  • 6. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT.
    Cancer Res; 2001 Apr 15; 61(8):3419-24. PubMed ID: 11309302
    [Abstract] [Full Text] [Related]

  • 7. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, Nakagawa M.
    Biochem Biophys Res Commun; 2006 Jan 20; 339(3):790-6. PubMed ID: 16316628
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.
    Carcinogenesis; 2008 Sep 20; 29(9):1845-9. PubMed ID: 18632757
    [Abstract] [Full Text] [Related]

  • 12. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
    Floyd HS, Jennings-Gee JE, Kock ND, Miller MS.
    Mol Carcinog; 2006 Jul 20; 45(7):506-17. PubMed ID: 16482519
    [Abstract] [Full Text] [Related]

  • 13. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.
    Cancer Res; 2001 Jan 01; 61(1):249-55. PubMed ID: 11196170
    [Abstract] [Full Text] [Related]

  • 14. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT, Lee SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2005 Apr 01; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [Abstract] [Full Text] [Related]

  • 15. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF.
    Clin Cancer Res; 2001 Jul 01; 7(7):1998-2004. PubMed ID: 11448917
    [Abstract] [Full Text] [Related]

  • 16. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
    Norrie MW, Hawkins NJ, Todd AV, Meagher AP, O'Connor TW, Ward RL.
    J Surg Oncol; 2003 Nov 18; 84(3):143-50. PubMed ID: 14598358
    [Abstract] [Full Text] [Related]

  • 18. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer.
    Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, Kelsey KT.
    Oncogene; 2001 Mar 29; 20(14):1765-70. PubMed ID: 11313923
    [Abstract] [Full Text] [Related]

  • 19. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY.
    Clin Cancer Res; 2002 Dec 29; 8(12):3669-75. PubMed ID: 12473575
    [Abstract] [Full Text] [Related]

  • 20. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
    Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S, Nakao A.
    Clin Cancer Res; 2001 Oct 29; 7(10):3135-8. PubMed ID: 11595706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.